![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Pharmacokinetic Profile of Single and Multiple Ascending Doses of GS-4182, an Oral Prodrug of Lenacapavir, in Participants without HIV-1
|
|
|
25th International AIDS Conference (AIDS 2024); July 22–26, 2024; Munich, Germany
Naveed Shaik, Renu Singh, Ramya Rao, Sean Regan, Deqing Xiao, Furong Wang, Stephen Lau, Jason Hindman*
Gilead Sciences, Inc., Foster City, CA, USA
*Presenting author
![0729241](../images/072924/072924-20/0729241.gif)
![0729242](../images/072924/072924-20/0729242.gif)
![0729243](../images/072924/072924-20/0729243.gif)
![0729244](../images/072924/072924-20/0729244.gif)
![0729245](../images/072924/072924-20/0729245.gif)
![0729246](../images/072924/072924-20/0729246.gif)
![0729247](../images/072924/072924-20/0729247.gif)
![0729248](../images/072924/072924-20/0729248.gif)
![0729249](../images/072924/072924-20/0729249.gif)
![07292410](../images/072924/072924-20/07292410.gif)
![07292411](../images/072924/072924-20/07292411.gif)
![07292412](../images/072924/072924-20/07292412.gif)
![07292413](../images/072924/072924-20/07292413.gif)
![07292414](../images/072924/072924-20/07292414.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|